| Mark J Silversmith, MD | |
|
11 Washington Pl, Bedford, NH 03110-6747 | |
| (603) 624-4450 | |
| (603) 606-3049 |
| Full Name | Mark J Silversmith |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 41 Years |
| Location | 11 Washington Pl, Bedford, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104825587 | NPI | - | NPPES |
| 30004816 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 8633 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catholic Medical Center | Manchester, NH | Hospital |
| Monadnock Community Hospital | Peterborough, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Medical Center | 6103897129 | 248 |
News Archive
ForeverGreen Worldwide Corp. announces the completion of its in-house fully functional information systems.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Milk can be lethal to babies with classic galactosemia, a rare genetic disorder that severely impairs the body's ability to process a milk sugar known as galactose and is associated with a host of neurodevelopmental issues.
› Verified 9 days ago
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559904 PECOS PAC ID: 6103897129 Enrollment ID: O20060801000346 |
News Archive
ForeverGreen Worldwide Corp. announces the completion of its in-house fully functional information systems.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Milk can be lethal to babies with classic galactosemia, a rare genetic disorder that severely impairs the body's ability to process a milk sugar known as galactose and is associated with a host of neurodevelopmental issues.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark J Silversmith, MD 11 Washington Pl, Bedford, NH 03110-6747 Ph: (603) 624-4450 | Mark J Silversmith, MD 11 Washington Pl, Bedford, NH 03110-6747 Ph: (603) 624-4450 |
News Archive
ForeverGreen Worldwide Corp. announces the completion of its in-house fully functional information systems.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Milk can be lethal to babies with classic galactosemia, a rare genetic disorder that severely impairs the body's ability to process a milk sugar known as galactose and is associated with a host of neurodevelopmental issues.
› Verified 9 days ago
Dr. Denis Brin Hammond, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 194 N Amherst Rd, Bedford, NH 03110 Phone: 603-472-8548 | |
Angel A Fernandez Segura, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9 Washington Pl Ste 204, Bedford, NH 03110 Phone: 603-624-4450 Fax: 603-606-3049 | |
Dr. Romil Y Patel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl Ste 115, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Geoffrey A. Lundy, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 25 S River Rd, Bedford, NH 03110 Phone: 603-695-2572 Fax: 603-695-6195 | |
Dr. Andrea H Greenfeld, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 25 Leavey Dr, Bedford, NH 03110 Phone: 603-314-6500 Fax: 603-314-6509 | |
Dr. Jennifer Fishbein, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 188 Route 101, Bedford, NH 03110 Phone: 603-314-4700 |